Geode Capital Management LLC Purchases 16,203 Shares of Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL)

Geode Capital Management LLC raised its position in shares of Cryo-Cell International, Inc. (NYSEAMERICAN:CCELFree Report) by 68.5% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 39,860 shares of the company’s stock after acquiring an additional 16,203 shares during the period. Geode Capital Management LLC owned approximately 0.49% of Cryo-Cell International worth $254,000 at the end of the most recent quarter.

Cryo-Cell International Price Performance

Shares of CCEL stock opened at $7.25 on Tuesday. The company has a market capitalization of $58.44 million, a P/E ratio of -6.84 and a beta of 0.49. Cryo-Cell International, Inc. has a 1 year low of $4.47 and a 1 year high of $9.50.

Cryo-Cell International (NYSEAMERICAN:CCELGet Free Report) last announced its quarterly earnings data on Tuesday, October 15th. The company reported $0.13 EPS for the quarter, beating the consensus estimate of $0.02 by $0.11. Cryo-Cell International had a negative net margin of 28.03% and a negative return on equity of 42.06%. The business had revenue of $8.07 million during the quarter.

Cryo-Cell International Dividend Announcement

The business also recently declared a — dividend, which was paid on Friday, November 29th. Stockholders of record on Friday, November 15th were issued a dividend of $0.25 per share. The ex-dividend date was Friday, November 15th. Cryo-Cell International’s dividend payout ratio (DPR) is presently -94.34%.

Cryo-Cell International Company Profile

(Free Report)

Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases.

Recommended Stories

Receive News & Ratings for Cryo-Cell International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cryo-Cell International and related companies with MarketBeat.com's FREE daily email newsletter.